Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 5
2002 1
2003 1
2007 1
2008 2
2009 1
2010 1
2011 1
2012 1
2013 3
2014 2
2015 3
2016 4
2017 5
2018 5
2019 9
2020 8
2021 6
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Lorenzi M, Ferro A, Cecere F, Scattolin D, Del Conte A, Follador A, Pilotto S, Polo V, Santarpia M, Chiari R, Pavan A, Maso AD, Da Ros V, Targato G, Vari S, Indraccolo S, Calabrese F, Frega S, Bonanno L, Conte PF, Guarneri V, Pasello G. Lorenzi M, et al. Among authors: del conte a. Oncologist. 2021 Aug 23. doi: 10.1002/onco.13951. Online ahead of print. Oncologist. 2021. PMID: 34424565 Free article.
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Finocchiaro CY, Rota A, Barbieri V, Bettini A, Bianco R, Borra G, Buffoni L, Bulotta A, Carta A, Cortinovis D, Costanzo R, Cusmai A, Danesi R, D'Argento E, Del Conte A, Franchina T, Gilli M, Gregorc V, Irtelli L, Landi L, Malorgio F, Mancuso G, Martelli O, Mazzanti P, Melotti B, Migliorino MR, Minotti V, Montrone M, Morabito A, Roca E, Romano G, Rossi A, Savio G, Tiseo M, Boscardini I, Piccolo L, Pilotto S, Malapelle U. Finocchiaro CY, et al. Among authors: del conte a. Transl Cancer Res. 2019 Jan;8(Suppl 1):S16-S22. doi: 10.21037/tcr.2018.12.32. Transl Cancer Res. 2019. PMID: 35117061 Free PMC article.
Combination of Chemotherapy and ALK Inhibitors in ALK-Positive NSCLC.
De Carlo E, Schiappacassi M, Del Conte A, Stanzione B, Bearz A. De Carlo E, et al. Among authors: del conte a. J Thorac Oncol. 2021 May;16(5):e31-e32. doi: 10.1016/j.jtho.2021.01.1612. J Thorac Oncol. 2021. PMID: 33896577 Free article. No abstract available.
The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.
Bearz A, De Carlo E, Del Conte A, Spina M, Da Ros V, Bertoli E, Revelant A, Stanzione B, Tirelli U. Bearz A, et al. Among authors: del conte a. Int J Mol Sci. 2022 Jun 30;23(13):7322. doi: 10.3390/ijms23137322. Int J Mol Sci. 2022. PMID: 35806325 Free PMC article. Review.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Dal Maso A, Lorenzi M, Ferro A, Pilotto S, Cecere F, Follador A, Polo V, Del Conte A, Sartori G, Giavarra M, Scattolin D, Indraccolo S, Frega S, De Maglio G, Menis J, Bonanno L, Calabrese F, Guarneri V, Conte P, Pasello G. Dal Maso A, et al. Among authors: del conte a. Future Oncol. 2021 Jul;17(19):2513-2527. doi: 10.2217/fon-2021-0356. Epub 2021 May 14. Future Oncol. 2021. PMID: 33988036 Free article.
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.
Reale ML, Chiari R, Tiseo M, Vitiello F, Barbieri F, Cortinovis D, Ceresoli GL, Finocchiaro G, Romano GD, Piovano PL, Del Conte A, Borra G, Verderame F, Scotti V, Nonnis D, Galetta D, Sergi C, Migliorino MR, Tonini G, Cecere F, Berardi R, Pino MS, Martelli O, Gelibter A, Carta A, Vattemi E, Pagano M, Zullo A, Ferrari S, Rossi A, Novello S. Reale ML, et al. Among authors: del conte a. Lung Cancer. 2020 Feb;140:71-79. doi: 10.1016/j.lungcan.2019.12.006. Epub 2019 Dec 16. Lung Cancer. 2020. PMID: 31884129
61 results